<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) December 6, 2000
MEDCARE TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-28790 87-0429962B
(State or other (Commission (IRS Employer
jurisdiction of incorporation) File Number) Identification Number)
1515 West 22nd Street, Oak Brook, Illinois 60523
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (630) 472-5300
<PAGE>
Item 5 - Other Events
---------------------
On November 29, 2000 the Company repurchased all of the outstanding Series B
Convertible Preferred Stock (81.5 shares) from the Series B Preferred
Shareholders. The purchase price was $1,366 per share for a total of $111,329.
The Securities Repurchase Agreement governing this transaction is listed as an
exhibit to this filing.
Item 7 - Financial Statements and Exhibits
------------------------------------------
C. Exhibits:
7. Securities Repurchase Agreement
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned herunto duly authorized.
Medcare Technologies, Inc.
(Registrant)
By: /s/ Ray Krauss
----------------
Ray Krauss
CEO and President
Date: December 6, 2000
